Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Dr. Jhrna M
Diabetic kidney disease (DKD) is a prevalent complication of diabetes mellitus and a leading cause of endstage renal disease. Renal tubular damage plays a significant role in the progression of DKD. Recent research has unveiled the potential role of Salt-Inducible Kinase 2 (SIK2) in preventing both the progression of DKD and renal tubular damage. SIK2, a protein kinase involved in glucose metabolism, energy homeostasis, and inflammation, has shown protective effects on the kidneys. Activation of SIK2 has been found to suppress inflammation, reduce oxidative stress, promote renal tubular cell survival, and enhance glucose metabolism. Moreover, SIK2 activation helps maintain the integrity of the renal tubular epithelial barrier, preventing tubular damage. These findings provide valuable insights into the development of therapeutic interventions targeting SIK2 activation for the prevention of DKD and renal tubular damage, potentially improving the lives of individuals with diabetes and reducing the burden of this debilitating condition. Further research is warranted to fully elucidate the underlying mechanisms and translate these findings into clinical applications.